Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01484457 · ClinicalTrials.gov registry record · Early Phase 1
Controlled Insulin Delivery: Combining Technology With Treatment
A Early Phase 1 study, sponsored by Sansum Diabetes Research Institute.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 19
- Enrollment target
NCT01484457 is a Early Phase 1 study that has completed, run by Sansum Diabetes Research Institute. The registered enrollment target is 19 participants.
The verdict
NCT01484457, a Early Phase 1 study, has completed, sponsored by Sansum Diabetes Research Institute.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 19 participants
- Enrollment target
Study Summary
Hypothesis: Closed-loop control systems for an artificial pancreas using multi-parametric model predictive control can be developed and evaluated safely in patients with Type 1 Diabetes Mellitus (T1DM) to control blood glucose concentrations. This study seeks to combine real-time continuous glucose sensing with automated insulin delivery in a closed-loop system that will achieve euglycemia in patients with T1DM. The end result of this line of research will be an artificial pancreas that will provide around-the-clock glucose regulation through controlled insulin delivery in response to detected patterns of change in glucose levels.
Interventions
- DEVICE Closed-loop session
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2008-07 |
| Est. Completion | 2010-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01484457
The ClinicalTrials.gov registry entry for NCT01484457 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sansum Diabetes Research Institute, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Closed-loop session is the first listed.
NCT01484457 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01484457 about?
NCT01484457 is a clinical study titled "Controlled Insulin Delivery: Combining Technology With Treatment". Hypothesis: Closed-loop control systems for an artificial pancreas using multi-parametric model predictive control can be developed and evaluated safely in patients with Type 1 Diabetes Mellitus (T1DM) to control blood glucose concentrations. This study seeks to combine real-time continuous glucose...
What is the current status of trial NCT01484457?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 19 participants. The study started on 2008-07. Estimated completion is 2010-01.
What interventions are being tested in trial NCT01484457?
The interventions under investigation include: Closed-loop session (DEVICE).
Who is sponsoring clinical trial NCT01484457?
This trial is sponsored by Sansum Diabetes Research Institute, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.